‘Body Brokers’ Review: Drug Abuse Is Big Business for More Than Just the Dealers

  • 📰 Variety
  • ⏱ Reading Time:
  • 58 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 63%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

BodyBrokers review: Director John Swab survived drug addiction to share this shocking exposé of how opportunists are exploiting a loophole in recovery programs

” is the first I can recall about the “treatment industry” itself, that multibillion-dollar sector dedicated to helping hard-drug users kick the habit, and its conclusion is startling: Addiction is a veritable money machine for doctors, therapists and pharmaceutical companies alike, a substantial number of whom thrive not on recovery but on repeat business.

“So how much are they paying you?” a seasoned customer asks Utah on his third day. A young actor with a dopey, childlike innocence, Kilmer gives the guy a blank stare in return. Utah had no idea that his fellow patients might be getting kickbacks; he’s there because he legitimately wants to quit. When we meet Utah and Opal, they’re leaning on convenience-store robberies and other degrading ways to score their next fix of crack or heroin, the couple’s poisons of preference. Of the two, Utah is more motivated to get clean, so he leaves Opal in Ohio and takes Wood’s invitation to New West — which feels every bit as glamorous as the movie’s opening infomercial suggests.

That’s just one of the scams Vin is running, all inspired by actual tricks opportunists use to game a system that was put in place to save lives. “Body Brokers” also shows Utah and Wood rounding up addicts to get Naltrexone implants — a pricey Frankenstein-like procedure, designed to block opiate receptors, for which a real-life San Diego doc was busted. These operations cost about $60,000 a pop, Vin explains, and a savvy surgeon can do 20 a day.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 108. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인